The placenta and trisomy 21;Placenta et trisomie 21

Gynecologie Obstetrique et Fertilite

Volumn 29, Issue 7-8, 2001, Pages 538-544

  Frendo, J L ^a   Muller, F ^b  

^a INSERM   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Cell fusion; Maternal serum screening; Pregnancy hormones

Indexed keywords

CELL DIFFERENTIATION; CLINICAL FEATURE; CONFERENCE PAPER; CYTOTROPHOBLAST; FEMALE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MENTAL DEFICIENCY; PLACENTA DEVELOPMENT; PLACENTA DISORDER; PRENATAL DIAGNOSIS; PRENATAL SCREENING; SYNCYTIOTROPHOBLAST; TRISOMY 21;

EID: 0034851851     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(01)00181-3     Document Type: Conference Paper

References (20)

1. Antenatal screening for Down's syndrome
2. Use of sonographic markers to determine the risk of down syndrome in second-trimester fetuses
3. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation
4. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities
5. Abnormal maternal serum chorionic go nadotropin levels in pregnancies with fetal chromosome abnormalities
6. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome
7. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome
8. Le cytotrophoblaste humain, un casse tête pour le biologiste
9. Human placental growth hormone
10. The physiology of placental lactogen in human pregnancy
11. Regulation of chorionic gonadotropin gene expression
12. Nonadipose tissue production of leptin: Leptin as a novel placenta-derived hormone in humans
13. Retinoids stimulate leptin synthesis and secretion in human syncytiotrophoblast
14. A quantitative analysis of placental vasculature in the third-trimester fetus with autosomal trisomy
15. Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down syndrome
16. Histomorphological features of chorionic vill at weeks of gestation in trisomic and chromosomally normal pregnancies
17. Defect of syncytiotrophoblast formation and hCG expression in Down's syndrome
18. L'hormone chorionique gonadotrope et ses differentes formes moléculaires
19. Hyperglycosylated hCG, a potential alternative to hCG in Down syndrome screening
20. hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease